Determination of primary amino acid sequence and unique three- dimensional structure of WGH1, a monoclonal human IgM antibody with anti-PR3 specificity

Clinical Immunology and Immunopathology

Volumn 89, Issue 1, 1998, Pages 35-43

  Davis, Jacquelyn A ^a   Peen, Elisabeth ^a   Williams Jr , Ralph C ^a   Perkins, Shane ^a   Malone, Christine C ^a   McCorMacK, Wayne T ^a   Csernok, Elena ^c   Gross, W L ^c   Kolaskar, A S ^b   Kulkarni Kale, Urmila ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PUNE   (India)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; COMPLEMENTARY DNA; GLUTAMIC ACID; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN MU CHAIN; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY WGH1; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ARTICLE; B LYMPHOCYTE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; MOLECULAR MODEL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS;

EID: 0032189983     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4582     Document Type: Article

References (30)

1. Godman G. C., Churg J. Wegener's granulomatosis: Pathology and review of the literature. Arch. Pathol. 58:1954;533-553.
2. Pinching A. J., Lockwood C. M., Pussell B. A., Rees A. J., Sweny P., Evans D. J., Bowley N., Peters D. K. Wegener's granulomatosis: Observations on 18 patients with severe renal disease. Q. J. Med. 52:1983;435-460.
3. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann. Intern. Med. 98:1983;76-85.
4. Hoffman G. S., Kerr G. S., Leavitt R. Y., Hallahan C. W., Lebovics R. S., Travis W. D., Rottem M., Fauci A. S. Wegener's granulomatosis: An analysis of 158 patients. Ann. Intern. Med. 116:1992;488-498.
5. Henshaw T. J., Malone C. C., Gabay J., Williams R. C., Jr. Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum. 37:1994;104-112.
6. Falk R. J., Jennette J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N. Engl. J. Med. 318:1988;1651-1657.
7. Nölle B., Specks U., Lüdemann J., Rohrbach M. S., DeRemee R. A., Gross W. L. Anticytoplasmic autoantibodies: Their immuno-diagnostic value in Wegener's granulomatosis. Ann. Intern. Med. 111:1989;28-40.
8. vanderWoude F. J. Review: The current status of neutrophil cytoplasmic antibodies. Clin. Exp. Immunol. 78:1989;143-148.
9. Kallenberg C. G., Brouwer E., Weening J. J., Tervaert J. W. Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int. 46:1994;1-15.
10. Falk R. J., Terrel R. S., Charles L. A., Jennette J. C. Antineutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. USA. 87:1990;4115-4119.
11. Ewert B. H., Jennette J. C., Falk R. J. Antimyeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int. 41:1992;375-383.
12. Gilligan H. M., Bredy B., Brady H. R., Hébert M. J., Slayter H. S., Xu Y., Rauch J., Shia M. A., Koh J. S., Levine J. S. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J. Exp. Med. 184:1996;2231-2241.
13. Williams R. C. Jr., Staud R., Malone C., Payabyab J., Byres L., Underwood D. Epitopes on proteinase-3 recognized by antibodies from patients with Wegener's granulomatosis. J. Immunol. 152:1994;4722-4737.
14. Finnern R., Pedrollo E., Fisch I., Wieslander J., Marks J. D., Lockwood C. M., Ouwehand W. H. Human autoimmune anti-proteinase 3 scFv from a phage display library. Clin. Exp. Immunol. 107:1997;269-281.
15. Strunz H. P., Csernok E., Gross W. L. Incidence and disease associations of a proteinase 3-antineutrophil cytoplasmic antibody idiotype (5/7 Id) whose anti-idiotype inhibits proteinase 3 - Antineutrophil cytoplasmic antibody antigen binding activity. Arthritis Rheum. 40:1997;135-142.
16. Ermel R. W., Kenny T. P., Chen P. P., Robbins D. L. Molecular analysis of rheumatoid factors derived from rheumatoid synovium suggests an antigen-driven response in inflamed joints. Arthritis Rheum. 36:1993;380-388.
17. Larrick J. W., Danielsson L., Brenner C. A., Wallace E. F., Abrahamson M., Fry K. E., Borrebaeck C. A. K. Polymerase chain reaction using mixed primers: Cloning of human monoclonal antibody variable region genes from single hybridoma cells. Biotechnology. 7:1989;937.
18. Robbins D. L., Kenny T. P., Coloma M. J., Gavilondo-Cowley J. V., Soto-Gil R., Chen P. P., Larrick J. W. Serologic and molecular characterization of a human monoclonal rheumatoid factor derived from rheumatoid synovial cells. Arthritis Rheum. 33:1990;1188-1195.
19. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S., Foeller C. Sequences of Proteins of Immunological Interest. 1991;U.S. Department of Health and Human Services, Washington. p. 339-511.
20. Biosym Molecular Simulation Release 95.0, October, 1995.
21. Fan Z. C., Shan L., Guddat L. W., He X. M., Gray W. R., Raison R. L., Edmundson A. B. Three dimensional structure of an Fv from a human IgM immunoglobulin. J. Mol. Biol. 228:1992;188-207.
22. Benedetti E., Morelli G., Nemethy G., Scherage H. A. Statistical and energetic analysis of side chain conformations in oligopeptides. Int. J. Peptide Prot. Res. 22:1983;1-15.
23. Ponder J. W., Richards F. M. Tertiary templates in proteins: Use of packing criteria in the enumeration of allowed sequences for different structural classes. J. Mol. Biol. 193:1987;775-791.
24. Hobohm U., Sander C. Enlarged representative set of protein structures. Protein Sci. 3:1994;522-524.
25. Ramachandran G. N., Sasisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 23:1968;283-438.
26. Stein, P. E. Leslie, A. G. W. Finch, J. T. Carrell, R. W. Crystal structure of the uncleaved ovalbumin at 1.95 Å resolution, J. Mol. Biol. 221, 941, 959.
27. Vriend G. What-If: A Molecular modelling and drug design program. J. Mol. Graph. 8:1990;52-56.
28. Corper A. L., Sohi M. K., Bonagura V. R., Steinitz M., Jefferies R., Feinstein A., Beale D., Taussig M. J., Sutton B. J. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nature Struc. Biol. 4:1997;374-381.
29. Fujinaga M., Chernaia N. M., Halenbeck R., Koths K., James M. N. G. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J. Mol. Biol. 261:1996;267-278.
30. Sibilia J., Benlagha K., Vanhille P., Ronco P., Brouet J. C., Mariette X. Structural analysis of human antibodies to proteinase 3 from patients with Wegener's granulomatosis. J. Immunol. 159:1997;712-719.